Prescient (ASX: PTX) shares jump 6% on new US patent
In an exciting update, Prescient Therapeutics (ASX: PTX) has announced that it has been granted a key...
In an exciting update, Prescient Therapeutics (ASX: PTX) has announced that it has been granted a key...
In an upbeat development, clinical-stage oncology company Prescient Therapeutics (ASX: PTX) has rolled out a second cell...
Prescient Therapeutics Limited (ASX: PTX), a clinical-stage oncology company, has taken another step towards advancing...
Prescient Therapeutics (ASX: PTX) signed off the March quarter with major progress made in its Cell...
Prescient Therapeutics Limited (ASX: PTX), a clinical-stage oncology company, has announced the opening of enrolment...
Cancer results from the mutation of normal cells to tumour cells because of interaction between...
ASX-listed biopharmaceutical company Prescient Therapeutics Limited (ASX: PTX) is leaving no stone unturned as it progresses towards...
Cancer is one of the significant causes of death worldwide. As per the World Health...
Biopharmaceutical company Prescient Therapeutics Limited (ASX: PTX) engaged in evolving personalized therapies for cancer has released its...
To fight the menace of cancer, there have been categorical and highly efficacious progress in...
To stay up to date with Prescient Therapeutics news and events, please register your details.